Morgan Stanley raises MGE Energy (MGEE.US) target price to $77, optimistic about renewable energy projects driving profit growth

After successfully completing the end-of-phase II meeting with the U.S. Food and Drug Administration (FDA), the phase III clinical trial plan for BPL-003 is progressing steadily and is expected to officially launch in the second quarter of 2026.

Main 24h Trends: More Large BTC Limit Sell Orders, Totaling $1.401 billions

The probability of a Fed rate cut in September this year is 80% according to Polymarket betting markets.

Loracle rebuilds HYPE long positions, totaling $1.57 million